Cargando…
Augmented humoral and cellular immunity against severe acute respiratory syndrome coronavirus 2 after breakthrough infection in kidney transplant recipients who received 3 doses of coronavirus disease 2019 vaccine
Diminished immune response to coronavirus disease 2019 (COVID-19) vaccines and breakthrough infection (BI) is a major concern for solid organ transplant recipients. Humoral and cellular immune responses of kidney transplant (KT) recipients after a third COVID-19 vaccination were investigated compare...
Autores principales: | Yang, Jinyoung, Lee, Kyo Won, Baek, Jin Yang, Bae, Seongman, Lee, Young Ho, Kim, Haein, Huh, Kyungmin, Cho, Sun Young, Kang, Cheol-In, Chung, Doo Ryeon, Peck, Kyong Ran, Park, Jae Berm, Kim, Sung-Han, Kim, Tae-Jong, Kim, Dong-Min, Ko, Jae-Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc. on behalf of American Society of Transplantation & American Society of Transplant Surgeons.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807455/ https://www.ncbi.nlm.nih.gov/pubmed/36739177 http://dx.doi.org/10.1016/j.ajt.2022.12.022 |
Ejemplares similares
-
Neutralizing activity against Omicron BA.5 after tixagevimab/cilgavimab administration comparable to those after Omicron BA.1/BA.2 breakthrough infections
por: Yang, Jinyoung, et al.
Publicado: (2023) -
Invasive Fungal Diseases in Kidney Transplant Recipients: Risk Factors for Mortality
por: Seok, Hyeri, et al.
Publicado: (2020) -
Clinical Utility of Sero-Immunological Responses Against SARS-CoV-2 Nucleocapsid Protein During Subsequent Prevalence of Wild-Type, Delta Variant, and Omicron Variant
por: Lee, Beomki, et al.
Publicado: (2023) -
228. Early Recurrent Postoperative Bloodstream infections in Living-Donor Liver Transplant Recipients
por: Kim, Si-Ho, et al.
Publicado: (2019) -
1106. Comparison of Diagnostic Power of Conventional Culture and Automated Blood Culture System with Pleural Fluid
por: Ho Lee, Young, et al.
Publicado: (2023)